Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Crexendo
CXDO
$193M
| $7.45K | ﹤0.01% |
997
+381
| +62% | +$2.98K |
2025 Q4
2 quarters
|
|
1877
Diageo
DEO
$52B
| $7.4K | ﹤0.01% |
92
-12
| -12% | -$969 |
2024 Q2
8 quarters
|
|
1878
Business First Bancshares
BFST
$1.03B
| $7.34K | ﹤0.01% |
+239
| New | +$6.75K |
2026 Q2
0 quarters
|
|
1879
CuriosityStream
CURI
$154M
| $7.31K | ﹤0.01% |
2,749
+1,963
| +250% | +$5.8K |
2024 Q4
6 quarters
|
|
1880
Arlo Technologies
ARLO
$1.56B
| $7.1K | ﹤0.01% |
527
+29
| +6% | +$393 |
2023 Q2
12 quarters
|
|
1881
Cullinan Oncology
CGEM
$967M
| $7.06K | ﹤0.01% |
388
-128
| -25% | -$1.9K |
2026 Q1
1 quarter
|
|
1882
Iridium Communications
IRDM
$4.76B
| $7.02K | ﹤0.01% |
128
+7
| +6% | +$299 |
2020 Q1
25 quarters
|
|
1883
Health Catalyst
HCAT
$127M
| $7.02K | ﹤0.01% |
3,527
| – | – |
2025 Q4
2 quarters
|
|
1884
Coherus Oncology
CHRS
$128M
| $6.82K | ﹤0.01% |
4,873
+957
| +24% | +$1.56K |
2025 Q3
3 quarters
|
|
1885
Hanmi Financial
HAFC
$960M
| $6.77K | ﹤0.01% |
209
-2,476
| -92% | -$73.9K |
2025 Q4
2 quarters
|
|
1886
iShares MSCI Japan Value ETF
EWJV
$757M
| $6.77K | ﹤0.01% |
154
| – | – |
2022 Q1
17 quarters
|
|
1887
Samsara
IOT
$24.6B
| $6.65K | ﹤0.01% |
205
-339,288
| -100% | -$10.5M |
2025 Q1
5 quarters
|
|
1888
Ingles Markets
IMKTA
$1.6B
| $6.56K | ﹤0.01% |
74
+9
| +14% | +$805 |
2013 Q2
52 quarters
|
|
1889
Cardiff Oncology
CRDF
$69.2M
| $6.25K | ﹤0.01% |
4,811
+2,558
| +114% | +$4.06K |
2026 Q1
1 quarter
|
|
1890
Citi Trends
CTRN
$402M
| $6.19K | ﹤0.01% |
107
| – | – |
2025 Q2
4 quarters
|
|
1891
Red Robin
RRGB
$172M
| $6.18K | ﹤0.01% |
+774
| New | +$3.44K |
2026 Q2
0 quarters
|
|
1892
ING
ING
$89.4B
| $6.12K | ﹤0.01% |
195
| – | – |
2021 Q2
20 quarters
|
|
1893
Black Diamond Therapeutics
BDTX
$102M
| $6.11K | ﹤0.01% |
3,303
-2,060
| -38% | -$5.04K |
2025 Q2
4 quarters
|
|
1894
Investar Holding Corp
ISTR
$380M
| $6.08K | ﹤0.01% |
203
-365
| -64% | -$10.4K |
2024 Q3
7 quarters
|
|
1895
Dakota Gold
DC
$680M
| $5.91K | ﹤0.01% |
1,387
-2,168
| -61% | -$11.7K |
2025 Q2
4 quarters
|
|
1896
Metallus
MTUS
$875M
| $5.91K | ﹤0.01% |
+316
| New | +$5.93K |
2026 Q2
0 quarters
|
|
1897
W&T Offshore
WTI
$611M
| $5.87K | ﹤0.01% |
+1,863
| New | +$6.91K |
2026 Q2
0 quarters
|
|
1898
MediaAlpha
MAX
$873M
| $5.83K | ﹤0.01% |
464
-8
| -2% | -$76 |
2025 Q3
3 quarters
|
|
1899
QuantumScape Corp
QS
$2.51B
| $5.81K | ﹤0.01% |
768
+169
| +28% | +$1.27K |
2022 Q3
15 quarters
|
|
1900
Xometry
XMTR
$5.37B
| $5.79K | ﹤0.01% |
60
-16,480
| -100% | -$1.18M |
2024 Q4
6 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.